Therapies for COVID-19-Related Persistent Olfactory Disorders: One of the Good Fruits of the Pandemic

Sven Saussez; Luigi Angelo Vaira; Giacomo De Riu; Jérome R. Lechien

doi:10.3390/pathogens12010072

Pathogens (Jan 2023)

Therapies for COVID-19-Related Persistent Olfactory Disorders: One of the Good Fruits of the Pandemic

Sven Saussez,
Luigi Angelo Vaira,
Giacomo De Riu,
Jérome R. Lechien

Affiliations

Sven Saussez: Department of Human and Experimental Oncology, Faculty of Medicine UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), B7000 Mons, Belgium
Luigi Angelo Vaira: Maxillofacial Surgery Operative Unit, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy
Giacomo De Riu: Maxillofacial Surgery Operative Unit, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy
Jérome R. Lechien: Department of Human and Experimental Oncology, Faculty of Medicine UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), B7000 Mons, Belgium

DOI: https://doi.org/10.3390/pathogens12010072
Journal volume & issue: Vol. 12, no. 1
p. 72

Abstract

Read online

At the beginning of 2021, the scientific community realized the burden of COVID-19-related persistent olfactory disorders (ODs). The percentage of those infected with COVID-19 who developed severe and persistent ODs [1–3] with devastating effects on their quality of life was 5 to 40% [4,5].

n/a

Published in Pathogens

ISSN: 2076-0817 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Medicine
Website: http://www.mdpi.com/journal/pathogens

About the journal

Abstract

Keywords